Successful prevention of severe allergic transfusion reactions with omalizumab.
Sensen ShiJingjing HanYao YaoYang XuDepei WuYing WangPublished in: Transfusion (2020)
This case suggests that omalizumab is a promising new alternative treatment for the prevention of severe ATRs.